Patient-reported outcomes in Takayasu's arteritis

Area of Science:

• Rheumatology
• Patient-Centered Care
• Health Outcomes Research

Background:

• Patient-reported outcomes (PROs) are vital for assessing patient experiences and treatment effects directly.
• There is a growing global emphasis on patient-centered care within rheumatology.
• Takayasu's arteritis (TAK) management and research require effective assessment of disease impact on patients' lives.

Purpose of the Study:

• To highlight the current lack of disease-specific PRO measures for Takayasu's arteritis (TAK).
• To underscore the limitations of generic PRO instruments in capturing TAK-specific effects on quality of life.
• To emphasize the ongoing development of specific outcome measures for TAK.

Main Methods:

• Review of existing literature on PROs in rheumatology and Takayasu's arteritis.
• Analysis of the utility of generic PRO instruments (e.g., Short Form-36) in TAK patients.
• Examination of current initiatives by the Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group.

Main Results:

• Generic PROs indicate impaired health-related quality of life (HRQoL), functional status, anxiety, and depression in TAK patients.
• Generic PROs are insufficient for detailing the specific impact of TAK on daily living and quality of life.
• The need for disease-specific PRO measures in TAK is evident.

Conclusions:

• Developing disease-specific PRO measures for Takayasu's arteritis is essential for accurate assessment of patient well-being.
• Such measures will improve clinical care and research by capturing the unique aspects of living with TAK.
• Ongoing efforts aim to provide validated tools for evaluating TAK patients' quality of life.